MEDP Medpace Holdings Inc

BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.

A substantial insider sell was reported on August 21, by Cornelius P. McCarthy III, Board Member at Medpace Hldgs MEDP, based on the recent SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that III sold 1,662 shares of Medpace Hldgs.

SAN DIEGO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) ( Nasdaq: GYRE ) , an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, ...

SAN DIEGO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) GYRE, an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, M.D., to its ...

MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.

ANGO benefits from NanoKnife, clinical milestones, and a balanced portfolio despite tariff headwinds.